Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Denardo

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Cancer Research|December 1, 1995
Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignanciesG L DeNardo, K R Lamborn, S J DeNardo, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting moleculesHuguette Albrecht, Monique Cosman, Maria Ngu-Schwemlein, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Serum stability of 67Cu chelates: comparison with 111In and 57CoW C Cole, S J DeNardo, C F Meares, et al.
Molecular Immunology|December 11, 1999
Critical Lym-1 binding residues on polymorphic HLA-DR moleculesL M Rose, C T Deng, S L Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.
International Journal of Oncology|June 15, 2006
Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting moleculesPatricia A Burke, Jeffrey P Gregg, Brandon Bakhtiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing miceSally J DeNardo, Zhengsheng Yao, Kit S Lam, et al.
Cancer|February 1, 1994
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3)G L DeNardo, L A Kroger, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphomaGerald L DeNardo, Arutselvan Natarajan, Saphon Hok, et al.
Anticancer Research|January 19, 1999
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocolS J Denardo, C M Richman, D L Kukis, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Cancer Research|December 1, 1995
Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignanciesG L DeNardo, K R Lamborn, S J DeNardo, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting moleculesHuguette Albrecht, Monique Cosman, Maria Ngu-Schwemlein, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Serum stability of 67Cu chelates: comparison with 111In and 57CoW C Cole, S J DeNardo, C F Meares, et al.
Molecular Immunology|December 11, 1999
Critical Lym-1 binding residues on polymorphic HLA-DR moleculesL M Rose, C T Deng, S L Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphomaR T O'Donnell, G L DeNardo, D L Kukis, et al.
International Journal of Oncology|June 15, 2006
Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting moleculesPatricia A Burke, Jeffrey P Gregg, Brandon Bakhtiar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing miceSally J DeNardo, Zhengsheng Yao, Kit S Lam, et al.
Cancer|February 1, 1994
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3)G L DeNardo, L A Kroger, S J DeNardo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphomaGerald L DeNardo, Arutselvan Natarajan, Saphon Hok, et al.
Anticancer Research|January 19, 1999
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocolS J Denardo, C M Richman, D L Kukis, et al.
Pageof 28